https://www.zacks.com/stock/news/2233209/why-doctor-reddy-s-rdy-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2233209
Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:346803781756493354
0
https://www.zacks.com/stock/news/2230194/why-doctor-reddy-s-rdy-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2230194
Feb 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:7363440825436045333
0
https://www.zacks.com/stock/news/2221076/why-doctor-reddy-s-rdy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2221076
Feb 05, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:6058751270033413785
0
https://www.zacks.com/stock/news/2220309/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2220309
Feb 02, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:2538733625223771560
0
https://seekingalpha.com/article/4666144-dr-reddys-laboratories-ltd-rdy-q3-2024-earnings-call-transcript?source=feed_tag_india
Jan 30, 2024 - Dr Reddy's Laboratories Ltd. (NYSE:NYSE:RDY) Q3 2024 Earnings Conference Call January 30, 2024 10:00 AM ETCompany ParticipantsRicha Periwal - IRParag...
0
sa:-6001018213054485065
0
https://www.zacks.com/commentary/2215536/3-generic-drug-stocks-to-watch-amid-improving-market-prospects?cid=CS-ZC-FT-industry_outlook-2215536
Jan 25, 2024 - With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
zc:315080323919066931
0
https://www.zacks.com/stock/news/2194715/journey-medical-derm-up-on-update-for-skin-disease-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2194715
Dec 07, 2023 - Journey Medical (DERM) plans to submit a new drug application (NDA) to the FDA for DFD-29 to treat rosacea in adults by 2023-end. Stock rises.
zc:8732660958002601884
0